IRD vs MTCH · rev $11.0M vs P/E 13, rev $3.48B
Opus Genetics, Inc. (IRD) versus Match Group Inc (MTCH) — a side-by-side from cached financials, not a winner call.
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
Match Group Inc (MTCH) is a internet content & information company listed on NASDAQ.
Latest reported IRD revenue for 2024-12-31 was $11.0M. Net income was -$57.5M. Revenue was down 42.3% from 2023-12-31 to 2024-12-31. IRD currently screens at market cap $35.7M.
Latest reported MTCH revenue for 2024-12-31 was $3.48B. Net income was $551.3M. Revenue was up 3.4% from 2023-12-31 to 2024-12-31. MTCH currently screens at market cap $8.24B and trailing P/E 13.5.
IRD currently screens at market cap $35.7M. MTCH currently screens at market cap $8.24B and trailing P/E 13.5.
Not investment advice. Open the IRD and MTCH stock pages for the full models.
Not investment advice.